Our story

Nanexa are pioneers in bringing the control, precision and versatility of Atomic Layer Deposition (ALD) technology to drug formulation.

Founded in 2007 by two postdoctoral researchers from the University of Uppsala determined to discover new capabilities for ALD beyond industrial electronics, Nanexa now has its first Phase I clinical study underway and is developing the world’s first GMP pharma manufacturing plant with industrial Atomic Layer Deposition capabilities.

Discover Nanexa’s extraordinary journey here

read the story

- Anders Johansson, Nanexa’s co-founder and Head of Intellectual Property, on Nanexa’s origins and development.